Phase 2 Study of TXA127 in Post-ischemic Stroke Patients

Clinical trial NCT06135103 · UNKNOWN

Trial details

NCT number: NCT06135103
Sponsor: Constant Therapeutics LLC
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Ischemic Stroke

Start date: 2023-11-26
Primary completion: 2024-12-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.